There are plenty of hands to take out any impatient shell players i think and this will be the only ex shell I'll keep. Every cent is 6 mil for their market cap in diluted terms -not counting milestone options which will be awesome if they're triggered anyway.
The licensing model is important to note as it equates to recurring revenue. Very important, and when you're dealing with critical systems like hospitals, they are unlikely to budge from what they know- especially when it makes such a strong first impression like Miya clearly does.
NRR Price at posting:
5.9¢ Sentiment: Buy Disclosure: Held